Skip to main content
Log in

Pentamidine-associated pancreatitis

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Summary

Two patients without risk factors or a prior history of pancreatitis developed acute pancreatitis soon after initiating pentamidine isethionate therapy forPneumocystis carinii pneumonia associated with the acquired immunodeficiency syndrome. In both patients the pancreatitis improved following medication cessation. One patient did not redevelop pancreatitis when he subsequently received inhaled pentamidine. Review of the literature revealed five previously reported cases of this drug reaction. Pentamidine-associated pancreatitis appears to develop within three weeks of initiating therapy and after receiving more than 1 g in cumulative dosage. Glucose abnormalities, renal insufficiency, and nonspecific abdominal pain may be early warning signs of pentamidine-associated pancreatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. King H, Lourie EM, York W: Studies in chemotherapy XIX: further report on new trypanocidal substances. Ann Trop Med Parasital 32:177–192, 1938

    Google Scholar 

  2. Drugs for parasitic infections. Med Lett Drugs Ther 26:27–34, 1984

    Google Scholar 

  3. WHO Expert Committee on Leishmaniasis. The Leishmaniasis Technical Report Series 701. Geneva, World Health Organization, 1984

    Google Scholar 

  4. Pearson RD, Hewlett EL: Pentamidine for the treatment ofPneumocytis carinii pneumonia and other protozoal diseases. Ann Intern Med 103:782–786, 1985

    PubMed  Google Scholar 

  5. Siegal SE, Wolff LJ, Boehner RL, et al: Treatment ofPneumocystis carinii pneumonitis: A comparative trial of sulfamethoxazole-trimethoprim versus pentamidine in pediatric patients with cancer: Report from the Children's Cancer Study. Am J Dis Child 138:1051–1054, 1984

    PubMed  Google Scholar 

  6. Wharton JM, Coleman DL, Wofsy CB, et al: Trimethoprimsulfamethoxazole or pentamidine forPneumocystis carinii pneumonia in the acquired immunodeficiency syndrome—a prospective randomized trial. Ann Intern Med 105:37–44, 1986

    PubMed  Google Scholar 

  7. Centers for Disease Control. Human immunodeficiency virus infection in the United States: a review of current knowledge. MMWR 36:1–20, 1987

    Google Scholar 

  8. Brivet F, Coffin B, Bedassa P, et al: Pancreatic lesions in AIDS. Lancet 2:570–571, 1987

    PubMed  Google Scholar 

  9. Bricaire F, Mardre C, Zoubi D, et al: Pancreatic disturbances and AIDS: An anatomopathological study.In Proceedings of the Third International Conference on AIDS, June 1987. Washington: International Conference on AIDS, 1987, p 187 (abstract)

  10. Zazzo JF, Pichon F, Regnier B: HIV and the pancreas. Lancet: 1212–1213, 1987

  11. Mallory A, Kern F: Drug induced pancreatitis: A critical review. Gastroenterology 78:813–820, 1980

    PubMed  Google Scholar 

  12. Johnston DH, Cornish AL: Acute pancreatitis in patients receiving chlorothiazide. JAMA 170:2054–2056, 1959

    Google Scholar 

  13. Haber CJ, Meltzer SJ, Present DH, et al: Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease. Gastroenterology 91:982–986, 1986

    PubMed  Google Scholar 

  14. Rominger JM, Gutierrez JG, Curtis D, et al: Methyldopainduced pancreatitis. Am J Dig Dis 23:756–758, 1978

    PubMed  Google Scholar 

  15. Batalden PB, Van Dyne BJ, Cloyd J: Pancreatitis associated with valproic acid. Pediatrics 64:520–522, 1979

    PubMed  Google Scholar 

  16. Murray JF, Felton CP, Garay SM, et al: Pulmonary complications of the acquired immunodeficiency syndrome: Report of a National Heart, Lung and Blood Institute Workshop. N Engl J Med 310:1682–1688, 1984

    PubMed  Google Scholar 

  17. Antonow DR: Acute pancreatitis associated with trimethoprim-sulfamethoxazole. Ann Intern Med 104:363–365, 1986

    PubMed  Google Scholar 

  18. Bouchard P, Sai P, Reach G, et al: Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 31:40–45, 1982

    PubMed  Google Scholar 

  19. Osei K, Falko JM, Nelson KP, Stephens R: Diabetogenic effect of pentamidine;in vitro andin vivo studies in a patient with malignant insulinoma. Am J Med 77:41–46, 1984

    PubMed  Google Scholar 

  20. Murphey SA, Josephs AS: Acute pancreatitis associated with pentamidine therapy. Arch Intern Med 141:56–58, 1981

    PubMed  Google Scholar 

  21. Salmeron S, Petitpretz P, Katlama C, et al: Pentamidine and pancreatitis. Ann Intern Med 105:140–141, 1986

    Google Scholar 

  22. Zuger A, Wolf BZ, El-Sadr W, et al: Pentamidine-associated fatal acute pancreatitis. JAMA 256:2383–2385, 1986

    PubMed  Google Scholar 

  23. Conte JE, Hollander H, Golden JA: Inhaled or reduced-dose intravenous pentamidine forPneumocystis carinii pneumonia: A pilot study. Ann Intern Med 107:495–498, 1987

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwartz, M.S., Cappell, M.S. Pentamidine-associated pancreatitis. Digest Dis Sci 34, 1617–1620 (1989). https://doi.org/10.1007/BF01537122

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01537122

Key words

Navigation